The table below shows Acurx Pharmaceuticals, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$6.79M
-$10.38M
-$9.80M
-$7.54M
-$5.01M
-$3.35M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-
-
-
-
-
-
Dividends paid
-
-
-
-
-
-
ACXP operating cash flow (10-K history)
Acurx Pharmaceuticals, Inc. reported operating cash flow of -$6.79M for fiscal year 2025. That is up 34.6% from -$10.38M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$3.35M (FY 2020) to -$6.79M. Figures come from the company's audited annual reports as filed with the SEC.